BACKGROUND
==========

The treatment of acute and chronic wounds continues to serve as a challenge for both physicians and healthcare providers. If these wounds exist for prolonged periods of time, they can cause disability and decreased quality of life for patients.^[@R1]--[@R3]^ The use of split-thickness skin grafts (STSGs) remains an effective technique for wound coverage and is commonly performed by plastic surgeons.^[@R3]^ STSGs play a key role in establishing wound re-epithelization and serve as an essential rung in the plastic surgeon's reconstructive.^[@R4]^

Traditionally, skin grafts are fixated to the recipient donor site using staples or sutures to permit appropriate adherence through mechanical affixation to the surrounding soft tissue.^[@R5]^ Negative pressure wound therapy (NPWT) and bolster dressings have also emerged as effective adjuncts to optimize graft take and prevent graft shearing during the early stages of healing.^[@R6],[@R7]^ Although these methods have demonstrated reliable results, various clinical and administrative considerations must be made.^[@R5]^ Furthermore, adjunctive wound vacuum-assisted closure (VAC) application requires significant health system resources, both administratively and clinically.^[@R8]^ NPWT system procurement is reliant upon insurance authorization, documentation, and multidisciplinary coordination for directed patient care, while also initiating the potentiality of postoperative issues, such as VAC malfunction. Conventional approaches, such as the use of staples and suture, for the fixation of STSG can be time consuming and often constitutes the most tedious part of the operation. These techniques can create difficulties in securing grafts over large, complex, defects and causing increased postoperative pain and numerous office visits for staple removal.

Fibrin glue (FG), such as Tisseel (TISSEEL: Baxter Healthcare Corp, Deerfield, Ill.), consists of a combination of clotting proteins and thrombin, which when applied, mimics the terminal end of the clotting cascade, thus promoting hemostasis and adherence.^[@R9]^ FG has been increasing in its utilization within a wide variety of surgical subspecialties.^[@R10],[@R11]^ Much of the emphasis regarding applications of FG within the realm of surgery, particularly in plastic surgery, has leveraged its hemostatic and adherence properties.^[@R11]^

Although the use of FG has reported successful outcomes in other areas of reconstructive surgery, current literature is lacking on the use of FG for STSG fixation, specifically in the nonburn patient population. The purpose of this pilot study was to assess the clinical and cost effectiveness of FG for STSG fixation by comparing wound healing outcomes to traditional, suture only (SO), fixation methods in a general wound reconstruction population.

METHODS
=======

Study Design and Patient Selection
----------------------------------

A retrospective comparative cohort study was conducted to analyze wound healing outcomes, operative time, length of stay, and costs associated with the use of FG for STSG fixation. This study was reviewed and approved by the Institutional Review Board of the University of Pennsylvania (protocol \# 829882). All patients who received an STSG by the senior author (JPF) between January 1, 2016, and March 1, 2018, were retrospectively identified and reviewed. Inclusion criteria consisted of patients of at least 18 years old and who underwent wound coverage with an STSG through either SO fixation or FG fixation. These patients were then separated based on the type of STSG fixation (SO versus FG) and matched based on wound size and wound location.

Overall, 20 patients underwent STSG placement by the senior author (JPF) and were included in the study, 10 of whom had undergone STSG fixation with FG. A comparison group consisting of the additional 10 patients underwent SO fixation and were then matched to the FG cohort based on wound location and wound size, in which all wounds had a minimum size of 175 cm^2^. Tisseel (TISSEEL) FG was utilized in all experimental cases for the FG group.

Demographic information was collected for all patients, including sex, age, body mass index, history of smoking, location of wound, and comorbidities such as peripheral vascular disease, hypertension, and diabetes mellitus. Additionally, perioperative factors such as wound size, wound etiology, wound-adjusted operative time, use of NPWT, wound age at the time of STSG placement (≥60 days), and number of operative debridements before engraftment were collected. Finally, postoperative outcomes were analyzed at 180 days post-STSG fixation, including time to STSG healing and graft complications.

Outcomes and Data Analysis
--------------------------

Primary study end points were graft take assessed at 180 days of post-STSG placement and STSG-related complications, defined as graft failure, seroma, and surgical site infection (SSI). Secondary outcomes included wound-adjusted operative times, length of hospital stay, time to 100% graft take, postoperative wound VAC use, and costs associated with the skin graft procedure. Time to 100% graft take was calculated from the day of the STSG procedure to the date of complete healing, determined at a postoperative clinic visit. Wound-adjusted operative time was determined by dividing the case length by the number of wounds receiving an STSG, to examine the time required to affix each graft. Operative times were adjusted based on the number of wounds patients had because some patients received STSGs on more than 1 wound.

The University of Pennsylvania's Department of Finance provided financial data for the index STSG procedure and any additional admissions or reoperations related to the index procedure, within 180 days of post-STSG application. For these encounters, total cost and total charges were collected. Descriptive statistics was conducted for patient demographics, wound characteristics, and postgraft outcomes. Univariate analysis using the Wilcoxon rank sum test and the Fisher's exact test was performed where appropriate. A *P*-value of less than 0.05 was defined as being statistically significant. All statistical analyses were performed using STATA (*STATA Statistical Software: Release 15*; StataCorp LLC, College Station, Tex.).

Operative Technique
-------------------

After introducing FG into his practice for STSG use on August 30, 2017, the senior author has used this fixation technique in the majority of his STSG cases. This operative technique is described schematically in Figure [1](#F1){ref-type="fig"}. All cases began with standard wound bed preparation consisting of debridement, irrigation, and hemostasis. An appropriately sized STSG is then harvested from a suitable donor site with the dermatome blade set to 11--13/1,000 inches. The graft is meshed 1.5:1 to optimize coverage and is cut to fit appropriately in the wound bed. The prepped wound bed is sprayed using a CO~2~-based sprayer system with a thin layer of FG to cover the wound bed in its entirety. In each case, approximately 4--6 cm^3^ of FG is used on the wound beds; however, a greater volume is often used for larger wounds. The graft is then promptly and carefully inset within the wound bed. After insetting the graft, the newly fashioned graft is then sprayed with FG to ensure complete graft fixation. After allowing 2--3 minutes for the FG to dry, wound dressings are applied, which consists of using bacitracin, ADAPTIC (Acelity L.P. Inc., San Antonio, Tex.), abdominal gauze pads pads, and Kerlix sterile gauze, and gently covered with an ACE wrap (3M; ACE, Maplewood, Minn.). Additional FG (2--6 cm^3^) is used at the STSG donor site to improve hemostasis and reduce postoperative pain.

![Flowchart summarizing intraoperative approach for the application of FG to STSG recipient site.](gox-7-e2187-g001){#F1}

RESULTS
=======

Twenty patients were selected based on skin graft fixation method (FG or SO), wound location, and wound size parameters. Ten patients with 18 wounds receiving FG fixation were compared with 10 patients with 11 wounds receiving SO fixation. Detailed patient demographics and wound characteristics, including healing outcomes, are outlined for each patient in Table [1](#T1){ref-type="table"} (FG cohort) and Table [2](#T2){ref-type="table"} (SO cohort). Of note, 4 patients who underwent FG fixation and 1 patient in the SO group were treated for multiple wounds, which can be attributable to the etiology of their respective wounds. Overall, groups were similar with no significant differences in sex, age, body mass index, presence of peripheral vascular disease, history of necrotizing fasciitis, and history of smoking (Table [3](#T3){ref-type="table"}). However, the incidence of hypertension was higher in the SO group, although not statistically significant \[2 (20%) FG versus 7 (70%) SO, *P* = 0.0698\]. The majority of wounds were confined to the lower extremity (80% FG, 80% SO), with 2 patients in each group having a wound located on the scalp and the perineum.

###### 

Demographic and Clinical Information for Patients Undergoing FG STSG Fixation

![](gox-7-e2187-g002)

###### 

Demographic and Clinical Information for Patients Undergoing SO STSG Fixation
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###### 

Comparison of Demographic Data Between Fibrin Glue and Suture Only STSG Patients

![](gox-7-e2187-g004)

Wound characteristics for both cohorts are delineated in Table [4](#T4){ref-type="table"}, further highlighting a lack of significant differences in average wound size (*P* = 0.857), average wound age greater than 60 days (*P* = 0.663), and number of preoperative debridements (*P* = 0.374). Additionally, wound location and wound type can be appreciated for similarities in anatomic location and etiology (Table [4](#T4){ref-type="table"}). A comparison of perioperative and postoperative outcomes for the FG and SO groups is expressed in Table [5](#T5){ref-type="table"}. Time to 100% graft take (20.2 days FG versus 29.4 days SO, *P* = 0.405), wound-adjusted operative time (34.9 versus 49.4 minutes, *P* = 0.0612), and length of hospital stay (2.8 versus 3.5 days, *P* = 0.306) were both lower in the FG cohort, although not statistically significant. Of the 11 patients who underwent suture-based STSG fixation, 10 patients received postoperative wound VAC treatment, whereas no patients with FG fixation received wound VAC placement (*P* \< 0.0001). Average time to 100% graft take was 20.2 and 29.4 days (*P* = 0.170) for the FG and SO groups, respectively.

###### 

Summary of Wound Characteristics for FG and SO Groups
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###### 

Comparison of Operative and Postoperative Characteristics

![](gox-7-e2187-g006)

Cost data are summarized in Table [6](#T6){ref-type="table"}, in regard to total charges and total direct cost for all patients. Average total charges for the FG and SO groups were \$120,336 and \$183,750 (*P* = 0.496), respectively. Average total direct costs were \$16,542 and \$24,266 (*P* = 0.545) for the FG and SO groups, respectively.

###### 

Summary of Total Cost, Charges, and Total Direct Cost for Patients Receiving Fibrin Glue Fixation and Suture Only STSG Fixation

![](gox-7-e2187-g007)

DISCUSSION
==========

The key properties of FG, hemostasis and adherence, have the potential to play a critical role in plastic and reconstructive surgery, particularly with respect to the success of skin grafting. Graft take is directly dependent on underlying hemostasis to prevent hematoma formation and sufficient graft fixation, to ensure direct contact with the underlying wound bed during the inosculation phase. The results from this preliminary study show no difference in outcomes between FG STSG fixation and SO STSG fixation with the added benefit of liberation from NPWT. Over the past decade, the evidence supporting the use of FG in surgery has increased exponentially in numerous specialties and procedures. In the plastic surgery literature alone, the efficacy of FG has been reported in mesh fixation for abdominal wall reconstruction, demonstrated reduced pain associated with skin graft donor sites, shown to minimize blood loss in facelift surgery and microvascular reconstruction, and as a means to prevent seroma in abdominoplasty, and other body contouring procedures.^[@R12]--[@R20]^

As other applications of FG are explored, adherence of skin grafts to underlying tissue as a means of promoting healing is a promising but not well-explored option. Risk of complications in STSG placement vary based on patient demographics, comorbidities, and recipient graft site.^[@R21]^ However, recent reports exploiting FG's adherent properties for skin graft fixation are increasing, especially in animal research^[@R22]--[@R26]^ and clinically in burn patients.^[@R27]--[@R29]^ These clinical studies, although small in quantity, have reported positive outcomes with fewer graft loss and a decrease in hospital stay.^[@R27]--[@R29]^

Although current literature regarding the use of FG is becoming more frequent, studies evaluating STSG fixation are thwarted by unmatched patient populations, with limited clinical outcomes, minimal follow-up, and lack a cost analysis. Only 2 studies in the literature have compared FG versus traditional approaches for STSG fixation in a general reconstructive, nonburn wound patient population. Reddy et al^[@R30]^ examined a prospective cohort of patients and compared surgical outcomes at 14 days of follow-up between groups whose STSGs were fixated using FG versus skin staples or suture. Despite the small cohort, lack of matched study participants, and short-term follow-up, the group anecdotally noted reduction in operating room duration, better hemostasis, and better graft fixation in the FG group. Han et al^[@R31]^ developed a similar prospective study with 30-day follow-up, which found statistically significant reductions in collection formation and graft necrosis and increased graft take, with FG fixation methods. The group concluded that FG's utility in STSG fixation was superior to suture- or staple-only fixation, despite the short-term follow-up analyses and lack of cost data.

The efficacy of FG for the fixation of large lower extremity wounds was expressed in this preliminary analysis based on 180 days of postoperative follow-up and detailed records regarding time to 100% graft take. There was only one instance of delayed graft healing in the FG group, which fully healed after 7 weeks of standard wound care and without any additional surgical interventions. Furthermore, comparing time to graft take between the 2 groups revealed no significant differences (20.2 and 29.4 days, *P* = 0.450), underscoring the likely similarities in the effectiveness and utility of FG.

A potentially added benefit of using FG for STSG fixation is a reduction in operative time. Average wound-adjusted operative time was more than 10 minutes less in the FG group, demonstrating a clear trend, though not statistically significant (*P* = 0.0612). Average adjusted operative time decreased from 49.4 to 34.9 minutes, which accounts for more than a 25% reduction in time for cases using FG for STSG fixation. In a larger study, we expect that statistical significance in operative times will emerge, especially in larger wounds with multiple sites and in challenging anatomical locations. The potential ability of FG to decrease operative time, coupled with no difference in clinical outcomes, solidifies its position as a valuable tool in the reconstructive surgeon's armamentarium.

One clear indirect benefit of FG for STSG fixation, in our practice, is liberation from NPWT, which has traditionally become a common adjunct for graft stability and facilitates graft incorporation. Additionally, the use of NPWT has been reported to enhance graft take and reduce the rate of reoperation, when compared with conventional dressings.^[@R7]^ However, the use of FG for STSG fixation is thought to buttress stabilization, whereas the wound dressing protects the graft, thus eliminating the need for an NPWT.^[@R6],[@R7]^ Ten of 11 wounds in the control arm of this study required postoperative wound VAC placement, whereas none of the patients' wounds in the FG cohort required a wound VAC (*P* \< 0.0001). This liberation from NPWT is inherent within the practice of the senior author when using FG, and further studies are needed to delineate the true clinical impact of specific wound dressings.

The process of obtaining NPWT systems can be cumbersome. Wound VAC orders, management, and removal require expenditure of healthcare resources, especially for the administrative team and mid-level providers. Perhaps underappreciated, the multistep process required for VAC management (Fig. [2](#F2){ref-type="fig"}) relies on considerable resource allocation and contains numerous potential setbacks at each step, from insurance company authorization to device application and associated device issues. Thus, through the use of FG, such resource allocations are avoided entirely. However, additional studies are needed to comprehensively assess the outcomes of different postoperative dressings after the FG fixation of STSG.

![Administrative and staff logistics and potential pitfalls associated with postoperative VAC procurement and use for STSG patients. Such logistical issues can be avoided in patients who receive FG for STSG fixation as they do not require wound VAC placement.](gox-7-e2187-g008){#F2}

Cost analysis revealed the total direct costs (\$16,542 FG versus \$24,266 SO; *P* = 0.545) and total charges (\$120,336 FG versus \$183,750 SO; *P* = 0.496) for the FG patients trended toward being less expensive compared with SO fixation. Although we recognize that this cost analysis does not provide distinct statistical differences between the groups, our study is able to highlight potential factors that provide a cost--benefit to using FG, including reduced operative time, decreased hospital stay, and the elimination of a wound VAC.

The use of FG for STSG fixation was fully adopted into the senior author's (JPF) practice on August 30, 2017, and has been used as the primary method of fixation for STSG. In this time, we have developed a standardized approach for utilizing FG for graft fixation (Figure [1](#F1){ref-type="fig"}). Early on, temporary staples were used to stabilize the graft and typically removed 1--2 minutes after the graft has dried. However, in the vast majority of recent cases, through proficiency of the operative technique, temporary fixation was not applied. Figure [3](#F3){ref-type="fig"} displays a representative case of a patient who had large lower extremity defects secondary to bilateral fasciotomy incisions on both the medial and lateral aspects of his lower extremities. This patient received 4 large STSGs, all of which were fixated using FG. Figure [3](#F3){ref-type="fig"}E and F displays the patient's postoperative result at 7 weeks. Patients with large wound defects or multiple wounds, such as this patient, can especially benefit from FG for the purposes of both operative efficiency and preventing need for wound VAC. This preliminary analysis provides evidence for the utility of FG for STSG fixation with potential benefits for both the patient and the healthcare system.

![Representative case example of a patient with 4 large lower extremity defects secondary to fasciotomy in need of STSG for coverage. A and B, Intraoperative photographs following debridement and wound bed preparation. C and D, Images immediately postoperatively. E and F, Images at 7 weeks of follow-up.](gox-7-e2187-g009){#F3}

However, there are various limitations to this study, inherent in the retrospective, nonrandomized, study design. Furthermore, due to the recent implementation of FG into our clinical practice, the patient population size was limited. These limitations contributed to an insufficiently powered analysis, resulting in minimal statistically significant differences in outcomes. The short-term, 180-day, follow-up was an acceptable limitation, as our goal was to analyze STSG-healing rates, which can be effectively evaluated in the first 6 months postoperatively. Furthermore, although NPWT liberation is associated with FG application, the use of NPWT after the SO fixation of STSGs is standard practice for the senior author. Thus, future prospective comparison studies analyzing outcomes of FG fixation and SO fixation with different postoperative dressings, such as bolster dressings, are needed. Additionally, a lack of consistent intraoperative microbiological specimen data limits the characterization of this patient population. Detailed study examining FG's effectiveness in the presence of different infectious organisms should be evaluated to further elucidate this concept.

Overall, this study succeeded as a preliminary study in comparing matched cohorts of patients undergoing FG fixation to SO fixation for STSG adherence. The implementation of FG for STSG fixation has the potentiality to benefit practice workflow, by minimizing healthcare expenditures, liberating both patients and providers from wound VAC procurement, and providing comparable clinical outcomes to SO fixation.

CONCLUSIONS
===========

Through this preliminary comparative study, the use of FG for STSG fixation has shown promising results when compared with traditional fixation methods, in the setting of clinical outcomes. Specifically, in our practice, a trend was identified toward reduced operative time and a diminished need for postoperative NPWT. Future research consisting of larger, prospective, randomized trials is warranted to better understand the clinical utility and cost effectiveness of FG for STSG fixation and the impact of various postoperative wound dressings on healing.

ACKNOWLEDGMENT
==============

The authors would like to thank Jeffery I. Rohrbach, MSN, for assistance in preparing and organizing relevant cost data for this study.

Published online 16 May 2019.

The research did not receive any specific grant from the funding agencies in the public, commercial, or not-for-profit sectors.

**Disclosure:** John P. Fischer, MD, MPH, FACS, reports no relevant conflicts of interest. He has received payments as a consultant for Becton-Dickinson, Gore, Integra Lifesciences, and Misonix Inc. No other authors have financial disclosures.
